Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1) : a randomised. double-blind, placebo-controlled, dose-escalation trial

1 Citations

Journal

  • Lancet

    Lancet 376 1467-1475, 2010

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571698600690340224
  • NII Article ID
    10030297686
  • Data Source
    • CiNii Articles

Report a problem

Back to top